Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Evaluation of the impact of neutralizing antibodies on IFNβ response.
Patient experience and practice trends in multiple sclerosis - clinical utility of fingolimod.
Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway.
Preclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drug.
Decoding diffusivity in multiple sclerosis: analysis of optic radiation lesional and non-lesional white matter.
Control of microglial neurotoxicity by the fractalkine receptor.
MAIT cells in autoimmunity, immune mediated diseases and airways disease.
Pharmaceutical approval update.
Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in Mice.
Evaluation of the circulating CD34(+), CD309(+), and endothelial progenitor cells in patients with first attack of optic neuritis.
EAE: imperfect but useful models of multiple sclerosis.
New evidence for teriflunomide in multiple sclerosis.
Application of metabolomics in autoimmune diseases: Insight into biomarkers and pathology.
The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis.
A case of neuromyelitis optica spectrum disorder associated with a limited cutaneous systemic sclerosis and Sjögren syndrome.
The Elderly Person With Multiple Sclerosis: Clinical Implications for the Increasing Lifespan.
Diagnostic work-up and therapeutic options in management of pediatric status epilepticus.
[Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? Comments.]
Prevalence of Multiple Sclerosis in Tuscany (Central Italy): A Study Based on Validated Administrative Data.
[The usefulness of 3T magnetic resonance in the differential diagnosis of ischemic optic neuropathy and inflammatory optic neuritis].
Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity.
CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17.
Progressive multifocal leukoencephalopathy in an immunocompetent patient?
Resolution of Acute Disseminated Encephalomyelitis Following Termination of Pregnancy.
LOTUS, a possible endogenous inhibitor of axonal degeneration, as a new biomarker for multiple sclerosis.

Pages